Cardiovascular Systems (CSII) Stock Price, News & Analysis

Company Overview

Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.

Key Stats

• Today's Range: $20.00 to $20.00
• 50-Day Range: $19.87 to $20.00
• 52-Week Range: $12.26 to $20.57
• Volume: 4,300 shs
• Average Volume: 765,906 shs
• Market Capitalization: $843.96 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CSII Stock Analysis - Frequently Asked Questions

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems, Inc. (NASDAQ:CSII) posted its earnings results on Wednesday, February, 8th. The medical device company reported ($0.20) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by $0.05. The business's revenue for the quarter was up 3.9% on a year-over-year basis.

What other stocks do shareholders of Cardiovascular Systems own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardiovascular Systems investors own include Meta Platforms (META), Netflix (NFLX), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA) and Home Depot (HD).

Company Calendar

• Last Earnings: 2/08/2023
• Today: 5/29/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Health Care Equipment
• Current Symbol: NASDAQ:CSII
• CIK: 1180145
• Web: www.csi360.com
• Phone: (651) 259-1600
• Fax: 612-677-3355
• Employees: 780
• Year Founded: 1989

Profitability

• EPS (Most Recent Fiscal Year): ($0.97)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$36.93 million
• Net Margins: -15.79%
• Pretax Margin: -15.73%
• Return on Equity: -15.39%
• Return on Assets: -11.93%

Debt

• Debt-to-Equity Ratio: 0.08
• Current Ratio: 6.04
• Quick Ratio: 4.92

Sales & Book Value

• Annual Sales: $239.84 million
• Price / Sales: 3.52
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $6.12 per share
• Price / Book: 3.27

Miscellaneous

• Outstanding Shares: 42,198,000
• Free Float: 40,594,000
• Market Cap: $843.96 million
• Optionable: Optionable
• Beta: 0.74